XML 40 R19.htm IDEA: XBRL DOCUMENT
v3.25.1

Loss Per Common Share | 3 Months Ended
--- | ---
Mar. 31, 2025
Earnings Per Share [Abstract] |
Loss Per Common Share | Loss Per Common Share The following table provides the computation of basic and diluted loss per common share (EPS) (in millions, except share and per share amounts):
| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
Basic and diluted EPS: |  |  |  |  |  |  |
Net loss | $ | (473) |  |  | $ | (312) |  |  |  |  |
Weighted average common shares outstanding (in thousands) | 658,880 |  |  | 655,847 |  |  |  |  |
Basic and diluted EPS | $ | (0.72) |  |  | $ | (0.48) |  |  |  |  |
The following were excluded from the calculation of diluted EPS because inclusion of such shares would be antidilutive (in thousands):
| Three Months Ended March 31, |  |
| 2025 |  | 2024 |  |  |  |
6.50% convertible senior notes | 61,728 |  |  | 61,728 |  |  |  |  |
Restricted stock unit awards | 1,836 |  |  | 4,318 |  |  |  |  |
In addition, for the three months ended March 31, 2025 and 2024, excluded from the calculation of diluted EPS because inclusion of such shares would be antidilutive, are certain shares underlying the warrants issued pursuant to (i) the payroll support program established under the Coronavirus Aid, Relief, and Economic Security Act (PSP1 Warrants), (ii) the payroll support program established under the Subtitle A of Title IV of Division N of the Consolidated Appropriations Act, 2021 (PSP2 Warrants), (iii) the payroll support program established under the American Rescue Plan Act of 2021 (PSP3 Warrants) and (iv) the Loan and Guarantee Agreement with the U.S. Department of Treasury (Treasury Loan Warrants). During the first three months of 2025, all of the PSP1 Warrants and Treasury Loan Warrants, 14.0 million shares and 4.4 million shares, respectively, were exercised at an exercise price of $12.51 per share and net settled in cash for $79 million. The table below provides a summary of the warrants outstanding as of March 31, 2025:
Warrants |  | Warrants Issued (shares, in thousands) (1) |  | Exercise Price ($) |  | Expiration
PSP2 Warrants |  | 6,576 |  | 15.66 |  |  | January 2026 to April 2026
PSP3 Warrants |  | 4,407 |  | 21.75 |  |  | April 2026 to June 2026
(1)The PSP2 Warrants and PSP3 Warrants are subject to certain anti-dilution provisions, do not have any voting rights and are freely transferable, with registration rights. Each warrant will be exercisable either through net share settlement or cash, at our option. The warrants were issued solely as compensation to the U.S. Government related to entry into the payroll support program agreements. No separate proceeds (apart from the financial assistance previously received in 2021 and 2020) were received upon issuance of the warrants or will be received upon exercise thereof.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration